Aurora Cannabis Inc. (ACB)
After hours: 04:48PM EDT
| Previous Close | 7.03 |
| Open | 7.01 |
| Bid | 6.90 x 3000 |
| Ask | 6.91 x 2200 |
| Day's Range | 6.87 - 7.03 |
| 52 Week Range | 3.71 - 18.98 |
| Volume | 3,172,583 |
| Avg. Volume | 4,645,568 |
| Market Cap | 1.371B |
| Beta (5Y Monthly) | 3.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.32 |
| Earnings Date | Nov. 08, 2021 - Nov. 12, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.32 |
- Motley Fool
Did Aurora Cannabis Give Investors Reasons for Hope With Its Fiscal Q4 Results?
Depsite its dreadful performance over the last two years, investors may still hold out a smudge of hope that things will turn around for Canada-based marijuana producer Aurora Cannabis (NASDAQ: ACB). After all, a cursory glance at its historical stock prices indicates that Aurora did make some investors wealthy in the past. Since it started selling medical cannabis in the first quarter of 2016, Aurora's share price rose by as much as 2,400% through early 2018.
- CNW Group
Aurora Announces Sponsorship of ALUS' New Acre Project to Fund Community Environmental Initiatives
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a New Acre Project sponsorship to support ALUS. The commitment is intended to fund environmental programs in the communities where Aurora facilities are located.
- Motley Fool
Aurora Cannabis Says It's Close to Profitability. Should Investors Believe It?
Cannabis producer Aurora Cannabis (NASDAQ: ACB) reported its fourth-quarter results in September. While the numbers weren't all that surprising -- sales were lackluster and the business remains unprofitable -- the one thing that stood out was the company's claim that it is again on track to post a profit.
